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Abstract.  Intracellular targeting may enable protein 
kinases with broad substrate-specificities,  such as mul- 
tifunctional Ca2+/calmodulin-dependent protein kinase 
(CaM kinase) to achieve a  selectivity of action in 
vivo. We have examined the intracellular targeting of 
three/i-CaM kinase isoforms. The ~-CaM kinase iso- 
form is targeted to the nucleus in transfected cells 
while the 8^- and 6c-CaM kinase isoforms are cyto- 
solic/cytoskeletal. A  chimeric construct of a-CaM ki- 
nase containing the 6B-CaM kinase variable domain 
is rerouted to the nucleus while the native tx-CaM ki- 
nase and chimeras of ix-CaM kinase which contain the 
~^- or 6c-CaM kinase variable domains are retained in 
the cytoplasm. Using site-directed mutagenesis,  we 
have defined a nuclear localization signal (NLS) within 
an  l 1-amino acid sequence, likely inserted by alterna- 
tive splicing,  in the variable domain of ~-CaM kinase. 
Isoform-specific nuclear targeting  of CaM kinase is 
probably a key mechanism in the selective regulation 
of nuclear functions by CaM kinase. 
CaM kinase is a multimer that can be composed of 
several isoforms. We find that when cells express two 
different isoforms of CaM kinase, cellular targeting is 
determined by the ratio of the isoforms. When an ex- 
cess of the cytoplasmic isoform of CaM kinase is 
coexpressed along with the nuclear isoform, both 
isoforms are localized in the cytoplasm. Conversely an 
excess of the nuclear isoform can reroute the cytoplas- 
mic isoform to the nucleus.  The nuclear isoform likely 
coassembles with the cytosolic isoform, to form a bet- 
eromultimeric holoenzyme which is transported into 
the nucleus. These experiments demonstrate isoform- 
specific targeting of CaM kinase and indicate that such 
~argeting  can be modified by the expression of multi- 
ple isoforms of the enzyme. 
ROWTH factors,  neurotransmitters  and  hormones 
typically modify intracellular  processes throughout 
the cell with high specificity and speed. Their action 
is often mediated by protein kinases  with broad substrate 
specificities  that  enable  them  to  coordinate  multiple  re- 
sponses.  However, the ability of such kinases to phosphory- 
late many proteins,  including non-physiological  substrates in 
vitro,  suggests that there must be mechanisms for refining 
their target specificity  in situ.  We have examined  this  is- 
sue by studying multifunctional  Ca2+/calmodulin-dependent 
protein kinase (CaM kinase or CaM kinase H), 1  a major in- 
tracellular mediator of Ca  2+ action (for review see Hanson 
and Schulman,  1992b). Our working model is a modification 
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of the targeting  subunit  hypothesis  (Hubbard and Cohen, 
1993). Stated simply, the hypothesis suggests that a targeting 
domain (or subunit) directs the catalytic domain (or subunit) 
of the kinase to the substrate locus. Positioning of the kinase 
near its substrate or target may occur via a nearby anchoring 
protein which interacts  with the targeting  domain or by di- 
rect binding  of this domain with the substrate.  Such target- 
ing, along with spariai/temporal  control of the Ca  2+ signal, 
may underlie target  specificity  of signal  transduction  via 
CaM ldnase. 
Some of nature's  solutions  for specificity  have been pro- 
vided by the study of other kinases and phosphatases.  Pro- 
tein phosphatase 1 is targeted to glycogen or myofibrils by 
virtue of a targeting  subanit which associates with its cata- 
lyric  subunit  (Hubbard  and  Cohen,  1993).  The  type II 
cAMP-dependent  protein kinase (PKA) is targeted via its 
regulatory subunit to binding  proteins on microtubules or 
postsynaptic density (Scott and Sodeding, 1992). Protein ki- 
nase C has been shown to translocate to receptor proteins 
that anchor it near its substrates (Smith and Mochly-Rosen, 
1992).  Such targeting  helps to specify which of the many 
substrates of the kinase/phosphatase would be phosphory- 
lated/dephosphorylated and to increase the efficiency of the 
reaction by increasing the local concentration of the kinase/ 
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achieved in different cell types by the selective expression of 
a ldnase/phosphatase isoform, intraceUular anchoring pro- 
tein, and substrates. 
CaM kinase is distributed in a wide variety of cell types 
where  it is  found localized in the cytosol, cytoskeleton, 
membrane, and nucleus. Its broad specificity and distribu- 
tion enables it to phosphorylate substrate proteins localized 
to the cytosol, cytoskeleton, membrane, and nucleus. It can 
thus regulate contractility, gene expression, synthesis and 
release of neurotransmitters, and ion permeation across cell 
membranes. For example, CaM kinase phosphorylates mi- 
crotubule-associated protein 2 (MAP-2) and tau on microtu- 
bules, phospholamban in sarcoplasmic reticulum, synapsin 
I on synaptic vesicles, and tyrosine hydroxylase  and pyruvate 
kinase in the cytosol (for review see Hanson and Schulman, 
1992b). 
How does CaM kinase participate in regulatory processes 
in the nucleus? A nuclear localization of a presumably non- 
neuronal form(s) of CaM kinase has been demonstrated by 
immunocytochemistry in fibroblasts and glioma cells (Ohta 
et al., 1990). Nuclear forms of CaM kinase may  be responsi- 
ble for the increasing number of nuclear functions being at- 
tributed to CaM kinase. It regulates nuclear envelope break- 
down in sea urchin eggs (Baitingcr et al.,  1990),  releases 
Xcnopus oocytes from meiotic metaphase arrest (Lorca et 
al.,  1993) and promotes maturation of oocytes (Watdmann 
et at., 1990), regulates G~-M transition in mammalian cells 
(Planas-Silva and Means, 1992),  and induces gene expres- 
sion via the phosphorylation of the CCAAT enhancer ele- 
ment-binding protein/3  (C/EBPfi) (Wegner et al.,  1992). 
Whereas activation of PICA frees its catalytic subunit so th~ 
it is no longer excluded from the nucleus (Nigg et al., 1985), 
there is no evidence to suggest that CaM kinase dissociates 
into monomers after activation. The large size of the kinase 
(a decameric protein of 500-600 kD) makes it unlikely to 
mediate nuclear events without specific targeting into the nu- 
cleus. In the absence of an identified nuclear isoform of mul- 
tifunctional CaM kinase, some researchers have begun to ex- 
amine other CaM kinases such as CaM ldnase I and CaM 
kinase IV which are monomeric and less likely to be ex- 
cluded from the nucleus. 
Multifunctional CaM ldnase is composed of a family of 
isoforms derived from four (~x, B, 3" and g) closely related 
genes (for review see Rostas and Dunldey, 1992).  Isoforms 
range in size from 54 to 60 kD and form multimers of 6-12 
subunits that can be larger than 500 kD. The or- and B-CaM 
kinase isoforms are restricted to the nervous system whereas 
the 3'- and 6-isoforms are present in essentially all tissues. 
Each gene may give rise to several isoforms by alternative 
splicing. Thus, o~ gives rise to ct and c~33 (tie),/$ to fl and if, 
3" to 3'^, "re and "re and ~ to at least six isoforms (Bennett 
and Kennedy, 1987; Benson et al., 1991; Edman and Schul- 
man,  1994;  Mayer et  at.,  1993;  Nghiem  et  at.,  1993; 
Schworer et al., 1993). 
Each CaM kinase isoform encodes a catalytic, regulatory, 
and association domain. The NHz-terminal half of each iso- 
form consists of the catalytic domain with inherent phos- 
photransferase activity. Under basal conditions, this activity 
is suppressed by a regulatory domain containing a kinase 
autoinhibitory  segment  and  an  overlapping  ealmodulin- 
binding segment which follow the catalytic domain. The 
COOH-terminat domain, termed the association/assembly 
domain, functions to assemble the subunits into a large mul- 
timeric structure and may localize the kinase within the cell 
by interaction with anchoring proteins.  The predominant 
difference between the isoforms is their variable domain 
which consists of 11-39 amino acid "inserts" flanking a con- 
served linker sequence between the catalytic/regulatory and 
association domains. Electron microscopic studies suggest 
that in the multimeric holoenzyme, the catalytic/regulatory 
domains form individual spherical particles which radiate 
via a  short tether from a  single central globular panicle 
formed by all the  association domains (Kanaseki et al., 
1991). Alternatively spliced sequences may be inserted on 
either the NH2- or COOH-terminal side of the conserved 
linker  segment  forming the  tether.  Thus,  inserts  on  the 
NH2-terminal side may be  physically closer to the cata- 
lyric/regulatory domain and could modify Ca2+/calmodulin 
affinity or substrate specificity.  Inserts on the COOH-termi- 
nal side would be part of the central globular particle and 
could serve to regulate the multimeric size of the kinase and 
its targeting to intracellular sites. 
Targeting of CaM kinase to distinct subcellular sites may 
be achieved by a variety of strategies. These include post- 
translational modification, targeting of mRNA followed by 
localized translation, and/or by alternative spliced inserts 
that direct differential localization within the cell. Some lo- 
calization of ~x-CaM kinase may be achieved by local synthe- 
sis in dendrites, a-CaM kinase mRNA is found in dendrites 
as well as cell bodies of neurons whereas t-CaM kinase is 
restricted to cell bodies (Benson et al., 1992; Burgin et al., 
1990).  Posttranslational modification of o-CaM kinase may 
be responsible for some of its targeting since the sarne appar- 
ent isoform is found soluble and on synaptic vesicles (Ben- 
fenati et al.,  1992). 
Molecular  cloning  of additional  CaM  kinase  isoforms 
provided us with an opportunity to determine whether iso- 
forms differ in their intracellular localization and to examine 
the locus responsible for differential localization. We report 
that ~-CaM kinase, an isoform recently cloned from rat 
heart, is differentially targeted to the nucleus. By contrast, 
several other isoforms are excluded from the nucleus. An 
11-amino  acid insert present in the variable domain of ~- 
CaM kinase appears to be responsible for the nuclear target- 
ing of CaM kinase. 
Materials and Methods 
Materials 
Restriction  enzymes  and other DNA modifying  enzymes  were obtained 
from OlBCO BRL (Gaithersburg, MD) and New England Biolabs (Beverly, 
MA). Taq polymerase was obtained from Perkin-Elmer  Cetus, (Norwalk, 
CT). PCR1000.12 cloning vector was obtained from In Vitrogan Corp (San 
Diego, CA). Antibodies and their sources were as follows: Anti-a-CaM ki- 
nase monoctonal antibody, CB-c~-2 (mouse ascites) was generated  in our 
laboratory as described previously (Baitinger et al., 1990); auti-hae~..~.~tu- 
tinin peptide (H) monoclonal antibody, 12CA5 was kindly provided by I. 
Wilson  and  is  now  available commercially  through  Berkeley  Antibody 
Company  (Richmond,  CA); rhodamine-labeled  anti-mouse affinity pure 
antibodies were obtained from Orgene Technica Corp.  (Durham,  NC). 
Methods 
Construction  of expremrton vectors. An oligonucleotide  coding  for the 
t8-amino acid haemagglutinin peptide  (14) was introduced between Set  ~ 
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oligonucleotide-directed  mutagenesis (see below).  The plasmid chosen for 
the expression of the wild-type,  chimeric, and mutant CaM kinase con- 
structs was the pCD derivative SR~ (Takebe et al.,  1988). b-CAM kinases 
were introduced into the EcoRI sites of SRa. 
Two unique restriction sites Mlul and Seal were inserted into a-CaM 
kinase (a-CaM kinase MS) by site-directed mutagonesis  (see below)  at 
amino acids 311 and 334, respectively. The cDNA encoding a-CaM kinase 
MS (1,512 bp including the EcoRI linkers) was introduced into the EcoR1 
site of PCR1000.12  vector to generate a-CaM klna~-PCR1000.12.  8A-, 
~-, and ~c-CaM kinase sequences between amino acids 310 and 367, 310 
and 344, and 310 and 333, respectively, were ampfified by PCR (see below). 
The amplified sequences were introduced into a-CaM kinnse-PCR 1000.12 
replacing the 62-bp fragment between the Mini and Scal  sites thereby 
generating  the chimeric a-(SA)-, a-(B)-, and ,-(&:)-CAM  kinases.  ~C.aM 
kinase was inserted into SRa via the Pstl-Kpnl sites. The chimeric a-(8)- 
CaM kinase-SRa and mutant chimeric a-(~)-CaM kinase constructs were 
generated by replacing the central 1100 Sinai and BglII fragment of oeCaM 
kinase-SRa  with  the  corresponding  piece  from  a-(8)-CaM  kinase- 
PCRI000.12 and mutant ~-(&s)-CaM kinase-Ml3 DNA, respectively. 
Oligonucleotide-directed Mutagenesis 
Site-directed  mutagenesis of w  and a-(8e)-CaM kinase (as M13-CaM ki- 
ease) was performed as described previously for a-CaM kinase (Hanson 
and Schulman, 1992a;  Waldmann et al.,  1990).  The c~-(8e)--CaM kinase- 
MI3 was  constructed by subeloning the a-(Se)-CaM kinase eDNA into 
M13 at the EcoRI site. The following nucleotides were used to generate the 
Mlul and Scal sites without changing the respective amino acids in or-CaM 
kinase: MluI site at 928 bp 5'-CGGACJAAGTrACGCGTGC~CACK?ATAG- 
3' ScaI site at 990 bp 5'-Cd3TGGTGTTAGTACTC'IEAGAGCtATTC-3'.  The 
following oligonucleotides  were used to replace the indicated amino acids 
in a-(~)-CaM kinase.  Single mutants: Lys 328 to Asn Y-CC_tAACTGGA- 
CTTCCt-t-HGTTTACCCCATCCGG-3';  Lys  329  to  Asn 5"CGAACT- 
GGACTICCTGTTCTTTACCCCATCCGG-Y;  Double mutant (Lys 328 to 
Asn; Lys 329 to Asn); 5'-CGAAC~CTTCCTGTTGTI'TACCCCATC- 
CGG-3' (See Fig.  1 A for amino acid numbering of mutants). 
Site-directed  mutagenesis was also used to "loop-in" a sequence coding 
for  the  18-amino  acid  haernagglutinin peptide  tag  sequence  (creating 
H-CaM kinase). The 90-mer oligonucleotide  used had the sequence 5'-CCG 
GGT GCA GGT GGT GGT CAG CTG AGC TCC AGG TCC GC~ GTA 
GTC AGG GAC GTC GTA CGG ATA AGG AGC TCC CGA AGC CAT 
GC~ GTC-3' and introduced the amino acid sequence GAPYPYDVP- 
DYAGPGAQL between Ser  3 and Thr  t. 
Mutations were identified by restriction analysis and confirmed by single 
strand DNA sequencing using the enzymatic dideoxynucleotide method 
with Sequenase  (United States Biochem. Corp., Cleveland, OH). Double 
stranded  mutant  DNAs  were  subcloned  into  a-CaM  kinase-SRct  or 
c~-(~d)-CaM kinase-SRa as described above. 
PCR Amplification 
All PCR reactions were c~gried out using the Twin Block thermal cycler 
system (Ericomp, Inc., San Diego, CA) and Taq polymerase.  The reactions 
involved an initial denaturation period of 5 rain at 94"C, followed by 25 cy- 
cles consisting of I rain at 94"C,  1.5 rain at 55"C, and 2 min at 72"C. Finally 
the amplification was completed with an additional cycle ending with a 10- 
rain extension period. Sense oligo-nucleotides  containing the Mlul site and 
antisense oligonucleotides  containing the Scal site were used in pairs to am- 
plify the isoform-specific  variable sequence of 6^-, 6s-, and 8c-CaM ki- 
llases. 
Expression of CaM Kinase Constructs 
COS-7 cells were maintained in DME with 10% supplemented calf serum 
(Hyclone Labs., Logan, UT) in a 10% CO2 incubator. Rat 208F fibroblast 
cells were maintained in DME with 10% FBS (Hyclone) in a 10% CO2 in- 
cubator. Calcium phosphate transfections were performed essentially as de- 
scribed previously  (Chen and Okayama,  1987). DNA (10-15 pg per lO-cm 
plate containing ~,70% confluent cells) was added as a coprecipitate with 
calcium phosphate in buffer containing 25 mM BES buffer, 140 mM NaCi, 
130 mM CaCI2, and 0.75 mM Na2HPO4 pH (6.95). Cells were mock trans- 
fected by the same procedure but received an SRa plasmid lacking the CaM 
kinase.  Transfected  cells were incubated in a 3% CO2 incubator for 16- 
18 h, transferred to the 10% CO2 incubator with a change of medium, and 
harvested 36-72 h later.  For biochemical studies, the transfected cells were 
scraped into 10 ml of cold PBS, pelleted gently and resuspended in cold 
homogenization buffer (50 mM Pipes pH 7.0, 10% glycerol,  1 mM EGTA 
and a cocktail of the following pmtease inhibitors: Benzamidine 20 mM, 
PMSF 1 mM, leupeptin 10 ~tg/ml and pepstatin 10 ~g/ml). Cells were dis- 
rupted by sonication in a water cup sonicator (Heat Systems-Ultrasonics) 
at maximal power for 40-60 s at 4°C and cell  extracts  were prepared by 
centrifugetion in a microfuge  at 13,000 g for 15 rain. Aliquots were snap 
frozen in dry ice and stored at -700C. 
Culture and Transfection of Neonatal 
Cardiac Myocytes 
Neonatal cardiac myocytes were prepared and cultured essentially as de- 
scribed previously (Sen et al.,  1988)  with a  few modifications.  Briefly 
whole hearts were isolated from 3-d old rats and minced in a balanced salt 
solution containing 0.2%  glucose.  The myocardial  cells were dispersed 
using pancreatin and collaganase type H at 370C, the supernatant was col- 
lected and the cells  were isolated by centrifugation in a clinical centrifuge 
at 1,200 rpm for 5 min. The minced hearts were incubated with fresh col- 
lagenase  and  pancreafin  and  the  myocardial  ceil  isolation  procedure 
repeated.  The dispersion steps were repeated, for a total of four times. The 
cells were pooled and plated at a density of "~1.5 x  106 cells per lO-cm 
dish in MEM containing 10% horse serum, 5% FCS and 1% antibiotics. 
More than 95 % of the cells stained positive for myosin indicating that very 
few flbroblasts were contaminating the myocyte culture.  Cultured neonatal 
cardiac myocytes were transfected 48 h later by calcium phosphate precipi- 
tation as described above. 
Immunocytofluorescence 
Transfected 208F fibroblasts or neonatal cardiac myocytes were transferred 
24-36 h later to polylysine-coated  glass coverslips.  After 12-15 h incuba- 
tion on the coverslips,  the cells were extensively  rinsed in PBS and fixed 
in 2 % HCHO in PBS for l0 rain. The cells were further fixed and permeabi- 
lized with cold CH3OH  for 3-5 rain. The fixed  cells were extensively 
washed in PBS and preincubated in 1% BSA (RIA grade) in PBS for l h. 
The cells were further incubated with a primary antibody to either a-CaM 
kinase or the peptide tag (H), for 2 h at 37"C. The cells were extensively 
rinsed in PBS and incubated with goat anti-mouse antibody coupled to 
rhodamine for 45 rain at 370C. The coverslips were mounted on slides with 
vectashield  mounting  medium  (Vector  Labs.,  Burlingame,  CA).  The 
fluorescence  was observed using a Zeiss Axioplan Universal microscope 
using 63x  and 100x  objectives. 
Additional Methods 
The activity of the transfected CaM kinases in the cell extract was assayed 
using a peptide substrate autocamtide 2 as described previously (Hanson 
et al., 1989). Assay conditions were similar to that previously described ex- 
cepting that the specific activity of the ['y-32p]ATP used was 1 Ci/mmole. 
Immunoblots were performed as previously  described (Baitinger et al., 
1990) using the anti-tag antibody or the anti-a-CaM kinase antibody and 
incubated for 2 h at room temperature at a dilution of 1:5,000 and 1:2,000, 
respectively. 
Results 
Generation and Expression of Epitope Tagged 6-CAM 
Kinase lsoforms 
We chose to examine the effect of isoform-specific inserts on 
intracellular localization using the &CaM kinase isoforms. 
&CaM kinase is expressed as multiple alternatively spliced 
forms (Fig.  1, A and B) which do not differ in their basic 
physical  and  catalytic  properties  (Edman and  Schulman, 
1994).  We  examined  6A-CaM kinase,  which  has  a  34- 
amino acid insert on the COOH-terminal side of the linker 
segment of the variable domain, B-CaM kinase, which has 
an  ll-amino acid insert,  and 6c-CaM kinase,  which lacks 
an insert in this position. 
To detect the cellular distribution of the transfected 6-CAM 
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8^-, ~-, and 6c-CaM kinases 
and the expression  of tagged 
6-CAM kinases (H-tA-, H-/in-, 
and H-tc-CaM kinases).  (A) 
Amino  acid  sequence  of the 
variable  domain  of 6A-, 6n-, 
and  6c-CaM kinases  and the 
generation of H-~-CaM kinase 
constructs.  The  variable  re- 
gion amplified by PCR intro- 
duces the Mlul and Scal sites 
at the two ends of  the amplified 
sequence at the positions indi- 
cated. The boxed amino acids 
represent the conserved linker 
sequence  within  the  variable 
domain. The consensus NLS, 
KKRK, is highlighted in bold. 
The  first  lysine  of the  NLS 
(K  32s) is the last residue of the linker sequence and is present in all 
the three 6-CAM kinases. The 18-amino acid HA peptide tag (H) 
was inserted at the NH2-terminal of the three 6-CAM kinases,  by 
mutagenesis as described  in Materials and Methods.  (B) Western 
blot analysis of the recombinant H-~-CaM kinase proteins.  Trans- 
fected COS cell lysates were subjected to SDS-PAGE and trans- 
ferred to nitrocellulose. The SRc~  transfected COS cell lysates were 
similarly immunoblotted as a control. The nitrocellulose blots were 
probed with anti-tag monoclonal antibody at a dilution of 1:5,000 
as described in Materials and Methods. lmmunoblotting of the H-8- 
CaM kinase transfected COS-'/lysates indicates that the H-6-CaM 
kinase subunits are specifically recognized by the anti-tag monoclo- 
nal antibody and migrate at expected positions on SDS polyacryl- 
amide gel (H-ta-61  kD; H-ts-56 kD; H-tc-CaM kinase-54 kD). 
kinases,  we  introduced  an  epitope  tag  into  each  one. 
An  18-amino  acid  segment  containing  a  sequence  from 
hemagglutinin  HA1  that  constitutes  the  antigenic  epitope 
for monoclonal  antibody  12CA5,  was  introduced  by  site- 
directed mutagenesis into the three 5-CAM kinases between 
Ser  3 and ThP, to generate the tagged constructs H-6^-CaM 
kinase,  H-~-CaM kinase,  and H-~c-CaM kinase (Field et 
al.,  1988; Wilson et al.,  1984). We checked the basic prop- 
erties of the three epitope tagged 5-CAM kinases in the SRc~ 
vector expressed  in  COS  cells  (Materials  and  Methods). 
Western blotting of SDS-PAGE of COS cell extracts using 
anti-tag antibody indicates that the three tagged kinases were 
expressed with a subunit size •2  kD larger than the corre- 
sponding  subunit  lacking the  tag  (H-~^, 61  kD;  H-tB,  56 
kD; H-tc, 54 kD) (Fig.  1 B).  Little or no proteolytic prod- 
Figure 2. The H-&CaM kinase constructs and the chimeric c~-(6)- 
CaM kinase constructs exhibit normal enzyme activity. COS cell 
lysates from ceils transfected with c~-CaM kinase, 8-CAM kinases 
containing the  18-amino acid haemagglutinin peptide-tag at their 
amino terminal  end (H-6^, H-tB-, H-/tc), or the chimeric  c~-(~)- 
CaM kinases (c¢-(/tA)-, c~-(~)-, c~-(tc)-) were assayed for CaM ki- 
nase activity as described  in Materials  and Methods.  The control 
or endogenous CaM kinase activity in COS ceils was assayed in ly- 
sates from COS ceils transfected with the SRc~ expression vector 
alone. 
ucts could be seen in these transfections. Furthermore, only 
a single prominent band was seen in each lane of the trans- 
fected COS cell extracts and no immunoreactivity was seen 
in  the  control  extract,  attesting  to  the  lack  of significant 
cross-reacting antigen in these cells. The presence of the epi- 
tope tag did not affect kinase function.  Each isoform was 
expressed as  well as a-CaM  kinase,  a  well characterized 
neuronal  isoform  (Fig.  2).  Ca2+/calmodulin-dependent 
phosphorylation of autocamtide-2, a  selective CaM kinase 
substrate, was increased 20-30-fold relative to mock-trans- 
fected cells.  Kinase activity was highly dependent on both 
Ca  2÷ and calmodulin. CaM kinase activity migrated on su- 
crose gradients as a characteristic multimeric holoenzyme of 
"~500 kD (data not shown) as previously found with the non- 
tagged isoforms (Edman and Schulman,  1994). 
Immunolocalization of H-tA, H-tB, and H-tc-CaM 
Kinase Transfected into 208F Fibroblasts 
The three tagged constructs, in the SR¢ expression vector, 
were transfected into 208F cells (fibroblasts) in order to de- 
termine whether alternative splicing affects the intracellular 
targeting of 5-CAM kinase. Cells were fixed 36 h after trans- 
fection and incubated with the anti-tag antibody (Fig. 3). A 
goat anti-mouse IgG coupled to rhodamine was used to de- 
tect the mouse monoclonal antibody by fluorescent micros- 
copy.  Approximately  20-40%  of the  cells  exhibited  im- 
munofluorescence,  indicating  a  transfection  efficiency  of 
20-40%.  Expression  of H-tA-CaM kinase and H-tc-CaM 
kinase resulted in a cytosolic immunofluorescence pattern, 
suggesting that these isoforms were cytosolic or cytoskeletal 
(Fig. 3, a and b). There was little or no immunofluorescence 
in the nucleus.  By contrast, all the immunofluorescence in 
H-SB-CaM  kinase  expressing  cells  was  nuclear  (Fig.  3,  c 
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targeted to the nucleus whereas 
5A- and  6c- are localized to 
the cytosol in transfected  208F 
cells.  208F  cells  (rat fibro- 
b/asts) transfeeted with H-6^-, 
H-~-, H-6c-CaM kinase con- 
structs  were  fixed and  ana- 
lyzed by indirect immunofluo- 
rescence  using  the  anti-tag 
antibody as described in Ma- 
terials and Methods.  The ef- 
ficiency  of  transfection  was 
,'~20--40%. (a) H-~A-CaM ki- 
nase-transfeeted  ceils;  (b) 
H-6c-CaM kinase-transfected 
cells;  (c) H-~-CaM kinase- 
transfected  cells;  (d)  phase 
contrast of specimen (c) in the 
same field showing the entire 
set of cells with their nuclei. 
Bar, 20 t~m. 
and d). Thus, the transfected H-Se-CaM kinase was almost 
exclusively targeted to the nucleus. The transfected cells ex- 
hibited varying degrees of CaM kinase expression, but in all 
cases the pattern of staining was identical in that the H-Se- 
CaM kinase was nuclear whereas H-/fA- and H-~c-CaM ki- 
nase were cytoplasmic. 
Generation and Expression of Chimeric CaM Kinases 
Does the 5e-CaM kinase-specific insert encode nuclear tar- 
geting information? The only differences in sequence between 
the three 6-CaM kinase isoforms are the isoform-specific in- 
serts present in 6A" and 5e-CaM kinases and absent in ~c- 
CaM kinase (Fig.  1 A). We therefore engineered chimeric 
kinases in which the 6A" and 5e-specific sequences were in- 
troduced in the corresponding position of o~-CaM kinase. 
Like ~c-CaM  kinase,  a-CaM  kinase lacks  inserts at both 
the NH2- and COOH-terminal sides of the conserved linker 
sequence and is normally not targeted to the nucleus (see be- 
low). Furthermore, a-CaM kinase is the best characterized 
CaM kinase and an isoform for which a specific antibody is 
available. 
We prepared CaM kinase chimeras to determine whether 
the  /t-specific sequences  would  reroute a  normally  cyto- 
solic/cytoskeletal a-CaM  kinase.  Unique  restriction sites 
were  introduced on  either  site  of the  variable  region  of 
o~-CaM kinase by site-directed mutagenesis (Fig. 4 A). The 
variable regions of 6^-, 5e,  and 6c-CaM kinases were am- 
plified by PCR using primers that included the identical re- 
striction sites at comparable positions (Fig.  1 A). This en- 
abled us to generate chimeras with the variable domains of 
the three 6-CaM kinase isoforms inserted into an identical 
position of or-CaM  kinase  (Fig.  4  A).  Expression  of the 
resulting chimeric constructs (referred to from here on as 
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pression  of  chimeric  a-(8)- 
CaM kinases. (,4) Generation 
of  chimeric a-(8)-CaM  kinase 
constructs.  Mlul and Scal sites 
were inserted into a-CaM ki- 
nase at positions identical to 
that of 8-CAM kinase, by site- 
directed  mutagenesis.  The 
PCR  amplified  variable  se- 
quences  of 8A-,  ks-,  and ~c- 
CaM kinases (Fig. 1 A) were 
inserted individually in place 
of the a-CaM kinase variable 
sequence  via  the  Mlul  and 
Seal sites (Materi~ and Meth- 
ods).  (B) Western blot anal- 
ysis  of chimeric  a-(8)-CaM 
kirmse  proteins.  Tmnsfect~ 
COS cell lysates were subjected 
to SDS-PAGE and transferred 
to nitrocellulose. The SRc~ transfected COS cell lysates were simi- 
larly immunoblotted as a  control. The nitrocellulose blots were 
probed with anti-a-CaM kinase monoclonal antibody at a dilution 
of 1:2,000 as described in Materials and Methods. Immunoblotting 
of the chimeric a-(8)-CaM kinase transfected COS-7 lysates with 
the anti-a-CaM kinase monoclonal antibody demonstrates that the 
chimeric CaM kinases are recognized  by the anti-a-CaM kinase an- 
tibody. They migrate on  SDS-polyacrylamide gels,  at positions 
predicted by the replacement of the a  variable region by the 8^-, 
ks, 6c-variable regions. 
tion with little or no immunofluorescence  detected in the cy- 
toplasm despite the high level of expression (Fig. 5, c and 
d). Comparison of the amino acid sequences of a-(~c)-CaM 
kinase (which has 23 amino acids derived from ~c-CaM ki- 
nase)  and a-(~)-CaM  kinase (which has 34  amino acids 
derived from B-CaM  kinase)  shows that there  is  an  l 1- 
amino  acid  insert unique  to  B-CaM  kinase  (Fig.  1 A). 
Since this insert is sufficient  to reroute a cytoplasmic a-CaM 
kinase to the nucleus, it is likely that it encodes information 
for nuclear targeting which functions independent of  the rest 
of the B-CaM kinase sequence. 
Nuclear targeting  of  B-CaM  kinase  and a-(~)-CaM  ki- 
nase does not appear to result  from the  generation  of  trun- 
cated  fragments or  unassembled subunits  that  would  be  small 
enough to  diffuse  passively  into  the  nucleus.  We needed to 
exclude such a  possibility  since  truncated  CaM  kinase  con- 
structs,  which lack  the association  domain, like  a-CaM ki- 
nase (1-326),  are expressed as monomers  of ~ 30-35 kD. 
These  monomers  express Ca2+/calmodulin-dependent  ki- 
nase activity  and are small enough to  passively  diffuse  into 
the nucleus (unpublished observations).  Several  properties 
of a-(~)-CaM  kinase suggest that  its nuclear targeting  is 
not due to such an artifact. First, the subunit size of the ex- 
pressed a-(~)-CaM kinase is commensurate with the size 
expected of full-length a(Ss)-CaM kinase. A  Western blot 
of cell  extracts  resolved  on  SDS-PAGE  using  the  same 
a-CaM  kinase-specific antibody used for immunofluores- 
cence does not detect smaller fragments (Fig. 4 B). Second, 
Ca2+/calmodulin-stirnulated phosphorylation of extracts from 
transfected cells reveals a predominant autophosphorylated 
56-kD  protein corresponding to a  full-length a-(ts)-CaM 
kinase (data not shown). Third, expressed a-(~s)-CaM ki- 
nase assembles appropriately into multimeric holoenzymes 
as determined by sucrose density centrifugation (data not 
shown). At least 95 % of CaM kinase activity sediments as 
a peak of ~500 kD with little activity in fractions sediment- 
ing at the monomer size.  Even if a  significant fraction of 
a-(~)-CaM kinase failed to assemble or was made smaller 
by truncation, it would still not give such a strikingly selec- 
tive localization in the nucleus as seen above (Fig. 5 c). 
a-(6^)-CaM  kinase,  ~(~)-CaM  kinase,  and  a-(~c)-CaM 
kinase) was first examined by transfecting the constructs into 
COS cells. The protein products were of the expected size 
and were specifically recognized by a monoclonal antibody 
to a-CaM kinase (Fig. 4 B). Each chimera produced a pro- 
tein kinase which was fully dependent on Ca2+/calmodulin 
for activity (Fig. 2). The level of expression was comparable 
to wild-type a-CaM kinase. 
lntracellular Targeting of Chimeric a-(~)-CaM Kinases 
a-CaM  kinase and the three chimeras were expressed in 
208F  cells and their intracellular targeting was examined 
with the anti-a-CaM kinase antibody. Native a-CaM kinase 
that lacked any 6-CaM kinase sequences was excluded from 
the nucleus and was broadly distributed within the cell to 
the cytosol/cytoskeleton (Fig.  5 a).  Similarly, 5(6^)-  and 
a-(~c)-CaM  kinases  were  cytoplasmic, with  little immu- 
nofluorescence seen in the nucleus (Fig.  5, b  and e).  The 
a-(~)-CaM  kinase exhibited a  distinctly nuclear localiza- 
The 6s-Specific Insert Has a Nuclear 
Localization Signal 
Comparison of the ll-amino acid insert in B-CaM ldnase 
with established nuclear localization signal (NLS) sequences 
of known nuclear proteins reveals that it has an NLS similar 
to that of SV40  T  antigen (SV40  TAg).  The core NLS 
of the SV40  TAg,  mKKRK (Kalderon et al.,  1984a),  is 
found identically in  the B-CaM  kinase-specific insert as 
mKKRK (Fig.  6).  Does this sequence serve as the NLS 
that is responsible for nuclear localization of B-CaM ki- 
nase? Extensive studies of NLS sequences indicate that the 
first Lys residue in the sequence KKRK is critical for nuclear 
targeting. For example, mutation of this Lys in the NLS of 
SV40 TAg to Ash or Thr disabled nuclear targeting via the 
NLS and led to the expression of the construct in the cytosol 
(Lanford and  Butel,  1984;  Kalderon et  aL,  1984a).  We 
therefore examined the role of the Lys residues in 32*KKRK 
of ~n-CaM  kinase by generating  site-directed mutants of 
a-(~)-CaM kinase in which either the first, second, or first 
two Lys residues in the KKRK sequence were substituted 
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of 8e- encodes a nuclear local 
signal  (NLS)  which targets  a 
cytosolic a-CaM kinase to the 
nucleus.  208F  ceils  transfected 
with wild-type o~-CaM kinase 
or chimeric  c~-(8,)-, c~-(se)-, 
or  ~,-(~c)-CaM  kinase  were 
fixed and analyzed by indirect 
immunofluorescence using the 
anti-or CaM  kinase  antibody 
(CB-ct-2)  as described in Ma- 
terials and Methods. The tram- 
foction  efficiency  was  ,~20- 
40 %. (a) o~-CaM  kinase-trans- 
fected cells;  (b)  a-(/J^)-CaM 
kinase-transfected  cells;  (c) 
a-(se)-CaM  kinase-~ 
cells; (d) phase contrast of c 
in the same field;  (e)  c~-(~c)- 
CaM kinase-transfected cells. 
Bar, 20/~m. 
SV40 TAg 
6B" CaM kinase 
OCB-CaM  kinase 
YA" CaM 14nase 
~SB  (tys328Asn) 
~S  (Lys  329Asn) 
-TPPKK~RKVEDPLA- 
-NDGVK~K~KSSSSVQLM  ................  ~ST 
-PDGVI~KRIKSSSSVQMMEST- 
-PDGVlqqI~KSSSSVQMMEST- 
~B  (Lys328ASnLys329Asn)  - PDGVNNRKS  S S SVQMMEST  - 
I 
328 
Figure 6.  Comparison of the insert sequence in the variable do- 
mains of 8e-, o~s-, and 7^-CaM kinases  with that of the SV40 TAg 
NLS. The consensus NLS, KKRK, is highlighted in bold. The CaM 
kinase isoform-specific  sequences in the variable domain, which 
are likely inserted by alternative  splicing,  are enclosed in a dashed 
with Asn. We shall use the convention of referring to these 
mutations  as  Ly#  2~m, Lys  329~m, or  Lys328AsaLys  329Ash, respec- 
tively  (Fig.  6).  As  before,  each  of these  mutated  c~-(6e)- 
CaM kinase chimeras were first characterized in COS cells. 
All three mutant proteins were expressed at comparable lev- 
els  and  demonstrated  the  characteristic  Ca2+/calmedulin  - 
box. The insertion of the isoform specific sequences  generates the 
NLS sequence,  KKRK, in 8e-, ¢xe-, and 1,,-CAM kinase  isoforms. 
The two lysines of the Be-CaM kinase NLS which were mutated to 
ASH arc  Lys  325 and Lys  329. The mutant 8e-CaM  kinase NLS se- 
quences (se- Lys  32s~a, 8e-Lys  329Ash, 8e-Lys328ASaLys329A~m)  arc high- 
lighted  in bold. 
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first or the second lysine of  the 
putative NLS pp~vents the nu- 
clear targeting of  CaM kinase. 
Fibroblasts  transfected  with 
a-(bB)-CaM kinase or mutant 
c~-(~)-CaM  kinases  were 
fixed and analyzed by indirect 
immunofluorescence  using the 
CB-,~-2 antibody. (a) a-(B)- 
CaM kinase-transfeeted cells; 
(b)  a-(~)-CaM  kinase- 
[Lys3~"]-transfeeted  cells; 
(c)  ,~-(~)-CaM  kinase- 
[Lys32~"]  -transfected  cells; 
(d)  a-(~)-CaM  kinase- 
[Lys32~Lys329~]-transfected 
cells. Bar, 20/~m. 
dependent CaM kinase activity (data not shown). Both the 
sequencing and functional expression of the mutants indi- 
cated that the mutant CaM kinase proteins were full-length. 
The ,-(~)-CaM kinase chimera, with and without muta- 
tions in the putative NLS, were transfected into 208F cells 
and their intracellular targeting was examined by immuno- 
localization as above. As previously observed, ~-(~)-CaM 
kinase was exclusively nuclear (Fig. 7 a). By contrast, muta- 
tion of the Lys  328 to Asn completely blocked the entry of 
ot-(~)-CaM kinase into the nucleus (Fig. 7 b). The Lys  32s^s" 
mutant could not be detected in the nucleus even after 72 h 
after transfection, thus clearly indicating that the mutation 
prevents, rather than just slows down the nuclear import. In- 
terestingly, the Lys  329'- mutant was also excluded from the 
nucleus as was the double mutant Lys  328~* Lyn  329~n. These 
experiments strongly suggest that this  site in ~B-CAM ki- 
nase functions as a NLS sequence that is critical for targeting 
the kinase to the nucleus.  Unlike the NLS of SV40 T  Ag, 
both the first and second lysine residues are necessary for nu- 
clear targeting of CaM kinase. 
6B-CaM Kinase Is Targeted to the Nucleus 
in Cardiac Myacytes 
We  determined  the  intracellular  targeting  of H-B-,  and 
H-tc-CaM kinase in cardiac myocytes, since the cDNAs for 
these isoforms were isolated from a  heart library (Edman 
and Schulman,  1994). Although B-CaM kinase is targeted 
to the nucleus in fibroblasts, it is possible that in cardiac cells 
its NLS is masked or overridden by the anchoring of the ki- 
nase  to  a  cytoskeletal or cytosolic protein.  We prepared 
cardiac myocytes from neonatal rats, transfected them with 
the H-6^-,  H-B-, and H-6c-CaM kinase constructs, and fol- 
lowed their localization with the anti-tag antibody as above. 
6B-CaM kinase was clearly targeted to the myocyte nucleus 
(Fig.  8  c)  whereas  the  6^-  and  ~c-CaM  kinase  were  ex- 
cluded from the nucleus and localized to the cytosol/cyto- 
skeleton (Fig.  8, a  and b).  We also examined the cellular 
targeting of the chimeric constructs in the cardiac myocytes. 
As  expected,  the  H-a-(~)-CaM  kinase  chimera  was  tar- 
geted  exclusively to  the  nucleus  whereas  H-or-(6^)-  and 
H-ot-(6c)-CaM kinase were localized to the cytoplasm (data 
not shown). 
Targeting of CaM Kinase Is Determined 
by the Ratio of Nuclear to Non-Nuclear lsoforms 
Expressed in the Cell 
CaM  kinase  may  consist  of holoenzymes  with  subunits 
which encode distinct targeting information. This is likely 
to occur since a number of cell types have been shown to ex- 
press more than one isoform. Neurons express at least the 
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the nucleus in transfected primary  rat 
cardiac myocytes. Neonatal rat cardiac 
myocytes  prepared  as  described  in 
Materials and Methods were transfected 
with H-6A-, H-B-, or H-6c-CaM kinase 
construct.  48  h  after transfection,  the 
cells were fixed and analyzed by indi- 
rect  immunofluorescence  using  the 
anti-tag  antibody. (a)  H-6A-CaM ki- 
nase-transfected  cells;  (b)  H-6c-CaM 
kinase-transfected cells; (c) H-t~-CaM 
kinase-transfected cells; (d) phase con- 
trast of c in the same field. Bar, 20 #m. 
cx and/3 isoforms of CaM kinase (Scholz et al.,  1988), lym- 
phocytes have at least two 7  isoforms and one 6  isoform 
(Nghiem et al.,  1993) and epithelial cells seem to express 
both -y and ~ isoforms (Nghiem et al.,  1993). Coexpression 
of or- and/~-CaM kinase cDNAs in CHO cells leads to the 
coassembly  of or- and  fl-CaM  kinase  subunits  to  form a 
holoenzyme (Yamauchi  et  al.,  1989).  Nuclear  and  non- 
nuclear isoforms may therefore assemble as heteromultimers 
and modulate intracellular localization of the two isoforms. 
We therefore asked whether nuclear and non-nuclear iso- 
forms can coassemble, whether coassembly occurs before 
targeting,  and  whether  coassembly  affects  targeting.  We 
cotransfected various pairwise combinations of nuclear and 
non-nuclear isoforms in which only one member of any pair 
contained the epitope tag or could be distinguished by an 
isoform-specific antibody.  Four  pairs  were  tested-H-cx- 
(&)-CAM  kinase  with  a-CaM  kinase,  ct-(&)-CaM  kinase 
with H-a-CaM kinase, &-CAM kinase with a-CaM kinase 
(distinguishable by u-CaM  kinase specific antibody), and 
H-6c-CaM ldnase with ~s-CaM kinase. 
We  cotransfected H-Sc-CaM  kinase  (cytosolic isoform) 
with a large excess (20-fold) of ~-CaM kinase (nuclear iso- 
form) into 208F cells and determined the cellular localiza- 
tion of H-6c-CaM kinase using  the anti-tag  antibody.  In- 
terestingly,  greater  than  99%  of  the  transfected  cells 
expressed H-6c-CaM kinase in the nucleus (Fig.  9,  a  and 
b).  Since 6c-CaM  kinase does not encode a  NLS and  is 
localized to the cytoplasm when expressed in the absence of 
any  other isoform (Fig.  3  b),  H-6c-CaM kinase is  likely 
coassembling  with  the  nuclear  ~-CaM  kinase  and  the 
holoenzyme is then being transported into the nucleus by the 
NLS  in  the  ~-subunits.  We  obtained  an  identical  result 
when we cotransfected a-CaM kinase with an excess of ~- 
CaM kinase. The cytosolic a-CaM kinase was rerouted by 
the  nuclear ~-CaM  kinase  subunlts  and  localized almost 
exclusively in the nucleus (Fig. 9, c and d). We observed a 
similar pattern of  ceUular staining when an excess of  the chi- 
meric  t~-(~)-CaM  kinase  (nuclear  isoform) was  cotrans- 
fected with the H-a-CaM kinase (cytosolic isoform). The 
H-a-CaM kinase was expressed in the nucleus of transfected 
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to the non-nuclear  isoform of 
CaM  kinase  expressed  in  a 
cell, determines the intracel- 
lular targeting of both the iso- 
forms  of CaM  kinase.  208F 
cells eotransfected  with a nu- 
clear and a  non-nuclear iso- 
form of CaM kinase eDNA at 
1:20 or 20:1 ratio by weight, 
were  fixed  and  analyzed by 
indirect  immunofluorescence 
using the anti-tag antibody (a, 
b, e, f,, and g) or anti-~x-CaM 
kinase  monoclonal antibody 
(c and d) (see Materials and 
Methods).  Cells were  trans- 
fected with the following CaM 
kinase constructs:  (a and b) 
6B:H-~c at 20:1; (c and d) ~: 
ot  at 20:1;  (e  and f)  ~x  (~): 
H-,~ at 20:1; (g) H-,~-(~):~x at 
1:20. (b, d, and f) phase con- 
trast of a,  c,  and e,  respec- 
tively. Bar, 20 #m. 
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f). Thus, an NLS-bearing isoform, either as a chimera or as 
a naturally occurring isoform can target the entire holoen- 
zyme to the nucleus when it is in excess of the coassembled 
non-nuclear isoforms. 
Cytosolic isoforms determine the cellular targeting when 
they are the dominant isoform subunits in the holoenzyme. 
Transfection of a  large excess (20-fold)  of or-CaM  kinase 
(cytosolic isoform) with H-ot-(~)-CaM kinase (nuclear iso- 
form) results in the localization of H-ot-(~)-CaM kinase in 
the cytosol in more than 99% of the transfected cells (Fig. 
9 g). A similar pattern of cellular distribution was observed 
when either 8c-CaM  kinase or a-CaM  kinase was trans- 
fected at a 20:1 ratio to H-~-CaM kinase (data not shown). 
These experiments indicate that CaM kinase isoforms can 
coassemble as  heteromultimers and that the  numerically 
dominant subunit in the holoenzyme determines its cellular 
targeting. 
Coexpression of the nuclear and the non-nuclear isoforms 
in intermediate ratios leads to an intermediate distribution 
of the holoenzyme within the cell. At a 10:1 ratio of o~-(~)- 
CaM kinase to H-a-CaM kinase, 91% of  the transfected ceils 
expressed the cytosolic isoform in the nucleus (Table  D. 
Decreasing the ratio of o~-(~)-CaM kinase to a-CaM kinase 
led to the localization of or-CaM kinase in both the cytoplasm 
and the nucleus. Thus, at a ratio of 1:1, less than 2% of the 
transfected cells expressed H-a-CaM kinase exclusively in 
the nucleus while 67 % of the cells expressed H-c~-CaM ki- 
nase  equally in the  nucleus  and in  the cytoplasm.  Con- 
versely, as the ratio of o~-CaM kinase to H-ot-(~)-CaM ki- 
nase was increased, none of the transfected cells expressed 
CaM kinase in the nucleus and an increasing number of cells 
expressed the nuclear H-~-(~)-CaM kinase isoform in the 
cytosol (Table I). For example at a 5:1 ratio of or-CaM kinase 
to H-ot-(~)-CaM kinase, none of the transfected cells ex- 
pressed  the  H-ot-(6B)-CaM  kinase  in  the  nucleus  while 
16.5% of the cells expressed the nuclear H-o~-(~)-CaM ki- 
Table I.  Cellular Dism'bution of CaM Kinase 
Protein after Coexpression of Nuclear and Non-nuclear 
Isoforms of CaM Kinase  (Percentage of CaM Kinase 
Expressing  Cells) 
~-(~):¢  N  N >  C  N =  C  N <  C  C 
10:1  91.3  8.7  0  0  0 
5:1  68.6  27.6  3.8  0  0 
2.5:1  26.5  50,3  23.2  0  0 
1:1  1.8  31.1  67.1  0  0 
1:2.5  0  4.8  28.5  63.5  3.2 
1:5  0  0  4.7  78.8  16.5 
1:10  0  0  6.1  10,2  83.7 
N, (% cells exhibiting nuclear staining); C, (%  cells exhibiting cytoplasmic 
staining). Varying ratios of ot-(~)-CaM kinase (nuclear) and ot-Cald kinase 
(cytoplasmic) were cotransfected into 208F cells. In the first four rows of the 
table, a-CaM kinase was tagged with a haemagglutinin peptide (H) in order 
to specifically  follow the cellular distribution of the or-CaM kinas¢ protein. In 
the last three rows the a-(~)-CaM kinase was tagged with the haemagglutinin 
peptide to follow the cellular localization  of a-(~)-CaM kinase. The number 
of transfected cells scanned per experiment was between 100 and 150.  The 
number  of  cells  showing  exclusively  nuclear  (N),  more  nuclear  than 
cytoplasmic (N > C), approximately equally nuclear and cytoplasmic (N ~ C), 
more cytoplasmic than nucler (N <  C) or exclusively cytoplasmic (C) staining 
with the anti-tag (H) monoclonul antibody, were expressed as a percentage of 
the total number of transfected cells examined. The scoring of the transfected 
cells was performed in a blind fashion. 
nase exclusively in the cytoplasm. These experiments clearly 
demonstrate that the ratio of the two isoforms in a holoen- 
zyme can determine the intracellular distribution of  the CaM 
kinase holoenzyme. 
Discussion 
This paper directly demonstrates isoform-specific targeting 
of  multifunctional CaM kinase. The enzyme has been known 
to localize at a variety of intracellular sites and it seemed rea- 
sonable to expect that its localization in a given cell would 
depend on the specific isoform being expressed and the com- 
plement of anchoring proteins  that the  kinase may bind 
(Rostas and Dunldey, 1992). Its differential concentration in 
postsynaptic density from forebrain  and  cerebellum  was 
postulated to be a result of targeting of the kinase to this neu- 
ronal specialization by the a-CaM kinase isoform (Miller 
and Kennedy, 1985).  We approached this issue directly by 
testing the targeting of distinct CaM kinase isoforms intro- 
duced into cells by transfection and identified a nuclear iso- 
form of the enzyme. We show that an NLS in a  11-amino 
acid insert sequence at the beginning of the association do- 
main of the ~-CaM kinase is responsible for targeting this 
isoform, ~-CaM kinase, to the nucleus. This NLS is simi- 
lar to the NLS of the SV40 TAg and fits the NLS consensus 
sequence, K-K/R-X-K/R, proposed by Chelsky and cowork- 
ers (Chelsky et al.,  1989;  Garcia-Bustos et al.,  1991). We 
have demonstrated that the first two lysines of the NLS are 
critical for nuclear targeting of CaM kinase as their replace- 
ment by asparagine, a neutral amino acid, prevents the nu- 
clear entry of CaM kinase. This NLS acts independently of 
any distal sequences of the ~-CaM kinase isoform since a 
chimeric construct of  c~-CaM kinase which contains the NLS 
from the ~-CaM kinase is rerouted from the cytosol to the 
nucleus.  In cardiac myocytes, which express  endogenous 
~-CaM kinase, the transfected ~-CaM kinase is targeted 
to the nucleus, suggesting that in its native environment the 
NLS targets ~-CaM kinase to the nucleus. Finally, we ob- 
serve that the intracellular targeting of the nuclear isoform 
is modified by coassembly with other isoforms of CaM ki- 
nase, generating a heteromultimeric holoenzyme. 
The first lysine of the NLS is present in the 6c-CaM ki- 
nase isoform which lacks any insert sequence and has the se- 
quence KEST (Fig.  1 A).  In the ~-CaM kinase isoform, 
the ll-amino acid insert sequence which begins with KRK 
is inserted between the residues K  and E of the sequence 
KEST. The insert sequences that constitute the variable do- 
main of CaM kinase are likely introduced by alternative 
splicing. In the case of ~-CaM kinase the insert sequence, 
KRKSSSSVQMM, is introduced after the last lysine of the 
previous exon, thus generating the sequence KKRKSSSSV- 
QMM (Fig. 1 A). It therefore appears that alternative splic- 
ing generates the NLS sequence, KKRK, which is responsi- 
ble for the nuclear targeting of ~-CaM kinase. 
Previous studies, based on kinase activity, immunoreac- 
tivity or function suggested the presence of CaM kinase in 
the nucleus. Sahyoun and coworkers (Sahyoun et al., 1984a, 
b) found a CaM kinase activity in the nucleus which phos- 
phorylated nuclear matrix proteins and chromatin proteins 
like HMG17, proteins that have been implicated in the regu- 
lation of RNA transcription. Ohta et al. (1990) presented im- 
munocytochemical evidence for a  nuclear localization of 
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1990).  CaM kinase has also been implicated in regulating 
various nuclear functions including nuclear envelope break- 
down,  G2-M  transition  in  mitosis  and  gene  expression 
(Baitinger  et  al.,  1990;  Planas-Silva  and  Means,  1992; 
Sheng et al.,  1991; Wegner et al.,  1992).  The  isoform- 
specific targeting of  CaM kinase to the nucleus reported here 
specifically identifies which isoforms may be present in the 
nucleus and suggests a possible mechanism by which target- 
ing is achieved. 
The NLS of the SV40 TAg, of which the ~-CaM kinase 
NLS is a prototype, has been extensively analyzed. Peptides 
and mutant constructs with this minimal NLS sequence have 
been demonstrated to target a variety of reporter proteins to 
the nucleus (Chelsky et al.,  1989;  Lanford et al.,  1986; 
Kalderon et  al.,  1984b).  Recently NLS-binding proteins 
have been  identified which bind  and transport  the NLS- 
containing proteins into the nucleus (Adam et al.,  1989; 
Adam and Gerace, 1991). The NLS has been shown to func- 
tion independent of its position in the protein (Kalderon et 
al., 1984b).  The first lysine residue of the NLS (KKRK) is 
critical for the nuclear targeting of the SV40 TAg (Kalderon 
et al.,  1984a;  Lanford and Butel,  1984).  Nuclear proteins 
more commonly use a bipartite NLS exemplified by nucleo- 
plasmin in which two clusters of positively charged residues 
separated by ten random amino acids are involved (Dingwall 
and Laskey, 1991; Robbins et al.,  1991). Mutation of resi- 
dues in any one cluster alone is not sufficient to completely 
prevent the nuclear targeting of nucleoplasmin. Each cluster 
encodes a weak nuclear-targeting signal and together the two 
clusters generate a strong NLS. The mutational analysis of 
the NLS of  CaM kinase is significant in that it clearly demon- 
strates  that unlike the bipartite NLS,  this  single NLS  is 
necessary and sufficient for its nuclear targeting. 
Replacement of either of the first two lysine residues of the 
NLS of ~B-CaM kinase with asparagine blocks nuclear tar- 
geting whereas only the first lysine in the SV40 T Ag NLS 
is essential. Changes in the other lysine residues of the SV40 
TAg NLS cause a partial defect in the nuclear targeting of 
the TAg but do not completely block it.  However,  even 
72 h after transfection, the Lys  329A'n mutant of o~-(~B)-CaM 
kinase is still completely excluded from the nucleus, suggest- 
ing that the second lysine of the NLS is also essential (Fig. 
7). It is possible that additional sequences in the SV40 T Ag 
stabilize the interaction of the NLS with the NLS-binding 
protein  and  therefore replacement of the  lysine residues 
other than the first one may not disrupt the overall interaction 
sufficiently. 
It is clear that the KKRK sequence, generated by the in- 
troduction of the  l 1-amino  acid  sequence  by  alternative 
splicing, is the NLS which targets ~-CaM kinase to the nu- 
cleus. The chimeric analysis further demonstrates that this 
NLS functions independently of any &CaM kinase specific 
sequences.  We  predict  that  other  CaM  kinase  isoforms 
which encode a similar KKRK sequence would be targeted 
to the nucleus. Both arCaM kinase and 3,A-CaM  kinase 
encode an identical NLS generated by the introduction of an 
1 l-amino acid and a 27-amino acid sequence, respectively, 
at a  corresponding position (Fig.  6).  Restricted PCR am- 
plification of brain cDNA has identified a partial a-CaM ki- 
nase like cDNA clone containing a 33-bp insert (encoding 11 
amino acids), likely inserted by alternative splicing  (Benson 
et al.,  199D. Indeed we find that a-CaM kinase containing 
the O/33 PCR fragment which encodes for the ll-amino acid 
insert sequence (aB-CaM kinase) is targeted to the nucleus 
(unpublished observations).  Thus, the nuclear localization of 
orB-CaM kinase further supports the role of the KKRK se- 
quence in targeting CaM kinase to the nucleus. 
Nuclear entry of CaM kinase may be modified by phos- 
phorylation or autophosphorylation. The phosphorylation of 
serine residues near the NLS of a variety of nuclear-targeted 
proteins like SV40  TAg,  modifies their nuclear targeting 
(Rihs et al., 1991). The four serine residues immediately fol- 
lowing the NLS sequence of/~-CaM kinase are candidates 
for regulatory phosphorylation. CaM kinase IV phosphory- 
lates  a  peptide  derived  from ~A-CaM kinase,  that corre- 
sponds to the/~ NLS-containing insert sequence (Miyano et 
al.,  1992).  Phosphorylation of these and other serine and 
threonine residues near the NLS of the nuclear CaM kinase 
isoforms could further modify the nuclear targeting of CaM 
kinase. 
The targeting of the transfected ~-CaM kinase to the nu- 
cleus of cardiac myocytes suggests that even in the native en- 
vironment of the cardiac cell, the NLS of ~-CaM kinase is 
available to the NLS-binding proteins and is not masked by 
an association of the kinase with some other cytosolic or 
cytoskeletal protein.  Rat heart contains both ~-  and 6c- 
CaM kinase isoforms but neither the isoform composition of 
the holoenzymes nor their localization in myocytes is known 
(Edman and Schulman, 1994).  Presumably the ratio of nu- 
clear to non-nuclear subunits and the amount of putative- 
anchoring proteins in the cytoplasm/cytoskeleton  will deter- 
mine the  distribution of the  endogenous CaM  kinase in 
heart. 
Previous studies suggest that the a- and B-CaM kinase iso- 
forms copurify and may therefore exist as a heteromultimer 
(for review see Rostas and Dunkley, 1992). Although a direct 
demonstration is still lacking, antibody specific to a-CaM 
kinase is reported to immunoprecipitate this isoform along 
with B-CaM kinase (Miller and Kennedy, 1985).  However, 
EM analysis suggests that the enzyme consists of homomul- 
timers of either a- or B-CaM kinase (Kanaseki et al., 1991). 
The potential for coassembly can be most easily tested by 
coexpressing identified isoforms and this approach has previ- 
ously been used to demonstrate coassembly of the two neu- 
ronal isoforms (a- and B-CaM kinases) (Yamauchi  et al., 
1989). The present study uses the same approach to demon- 
strate the formation of heteromultimers composed of two 
non-neuronal isoforms of CaM kinase and of one neuronal 
and one non-neuronal isoform of CaM kinase. It appears that 
many cells and tissues express more than one isoform of 
CaM kinase and we show that several combinations of het- 
eromultimers are possible. It will therefore be necessary to 
define which specific isoforms can coassemble before cellu- 
lar targeting of CaM kinase can be understood. 
The number of nuclear vs non-nuclear subunits of  CaM ki- 
nase appear to determine the subeellular targeting of CaM 
kinase. For example, the gradual decrease of the transfected 
nuclear isoform as compared to the non-nuclear isoform is 
accompanied by a decrease in nuclear localization of both 
subunits and a concomitant increase in their cytosolic/cyto- 
skeletal localization. In a cell, the isoform composition of 
the holoenzyme is probably dependent on the concentration 
of each subunit being synthesized and the nature of the as- 
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coassemble.  The level  of expression  of the individual iso- 
forms could be differentially regulated at the level of RNA 
transcription, translation, or processing.  In addition, CaM 
kinase  mRNA shows distinct localization  in the brain. In 
particular, oeCaM kinase mRNA is present in dendrites but 
/3-CAM kinase  is not (Benson  et al.,  1992; Burgin et al., 
1990).  Thus,  the cell body  may contain  heteromultimers, 
since mRNAs  for both a- and 13-CAM kinase isoforms are 
present there,  whereas  dendrites  probably contain  homo- 
multimers of CaM kinase which contain only or-CaM ldnase 
subunits. The potential interaction of multiple isoforms of 
CaM kinase introduces one more level at which the cellular 
localization  of CaM kinase may be regulated and therefore 
introduces another mechanism for the regulation of its cellu- 
lar functions. 
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